HF
ASMB icon

HRT Financial’s Assembly Biosciences ASMB Stock Holding History

HRT Financial’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,543
Closed -$25K – 2290
2023
Q4 		$25K Buy
+2,543
New +$24.2K ﹤0.01% 2017
2022
Q3 		– Sell
-1,753
Closed -$44K – 2773
2022
Q2 		$44K Sell
1,753
-681
-28% -$15.7K ﹤0.01% 2521
2022
Q1 		$60K Buy
+2,434
New +$52.3K ﹤0.01% 2726
2021
Q3 		– Sell
-7,242
Closed -$337K – 3253
2021
Q2 		$337K Buy
7,242
+4,619
+176% +$229K ﹤0.01% 2073
2021
Q1 		$144K Buy
2,623
+228
+10% +$15.1K ﹤0.01% 2392
2020
Q4 		$173K Buy
+2,395
New +$281K ﹤0.01% 1526

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's ASMB Position: Q1 2024 in Review

HRT Financial sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 2,543 shares — an estimated $25K sold.

HRT Financial first reported a position in ASMB in Q4 2020 and held it in 6 quarters. The position peaked at $337K in Q2 2021. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • HRT Financial reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 2,543 Assembly Biosciences shares in Q1 2024, an estimated $25K.
  • HRT Financial first reported a position in Assembly Biosciences in Q4 2020 and held it in 6 quarters.
  • HRT Financial's Assembly Biosciences position peaked at $337K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.